NCT02475109View on ClinicalTrials.gov

Study of Topical Ocular PAN-90806 in PDR

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions
Diabetic Retinopathy
Interventions
DRUG

PAN-90806 Ophthalmic Solution

Trial Locations (2)

78503

Valley Retina Institute, McAllen

78550

Valley Retina Institute, Harlingen

Sponsors

Lead Sponsor

PanOptica, Inc.
All Listed Sponsors
lead

PanOptica, Inc.

INDUSTRY